Who Paid My Doc
Maryann Decker
Optometrist, Corneal and Contact Management Eynon, PA Doctor of Optometry
NPI 1275651952 CMS profile 485895
810 Scranton Carbondale Hwy, C/O Pearl Vision, Eynon, PA 18403
General payments
$41
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Maryann Decker of Eynon, PA is reported in the CMS Open Payments database as having received $41 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 7th percentile of Optometrist, Corneal and Contact Management profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $16 | 1 | |
| 2019 | General | $25 | 1 |
Beside peers
- Maryann Decker
- Optometrist, Corneal and Contact Management median
- Middle half of Optometrist, Corneal and Contact Management
- National median
In program year 2025, general payments to Maryann Decker were reported at $0. Among 618 Optometrist, Corneal and Contact Management profiles paid that year, the median was $227 and the middle half received between $95 and $604.
Show as a table
| Year | Maryann Decker | Optometrist, Corneal and Contact Management median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $25 | $203 | $84–$530 | $163 |
| 2020 | $0 | $88 | $35–$234 | $114 |
| 2021 | $0 | $143 | $54–$353 | $132 |
| 2022 | $0 | $167 | $65–$422 | $149 |
| 2023 | $16 | $195 | $76–$549 | $160 |
| 2024 | $0 | $202 | $85–$523 | $164 |
| 2025 | $0 | $227 | $95–$604 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 2 billing codesPaid by Medicare
$1,151
Medicare patients
22
Services billed
23
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Optometrist, Corneal and Contact Management in Pennsylvania
Monika Marczak
Optometrist, Corneal and Contact Management · McMurray, PA
John Boyle
Optometrist, Corneal and Contact Management · Scranton, PA
Cody Sherrin
Optometrist, Corneal and Contact Management · York, PA
Mary Nguyen
Optometrist, Corneal and Contact Management · Springfield, PA
Lowell Lebovitz
Optometrist, Corneal and Contact Management · Pittsburgh, PA
Sandy John
Optometrist, Corneal and Contact Management · Plymouth Meeting, PA
Related records
Optometrist, Corneal and Contact Management in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Optometrist, Corneal and Contact Management
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.